Source comparison
Sermorelin Sleep Protocol: Research Model Comparison
Dosage Range 200–300mcg 300–500mcg 250–400mcg Lower doses sufficient for sleep alone; higher doses support tissue repair Injection Timing 30–60 min pre-sleep 45–60 min pre-sleep 30–45 min pre-sleep Timing aligned with anticipated slow-wave onset Frequency Nigh
This comparison does not assign a generated winner or score.
- Dosage Range
- 200–300mcg
- 300–500mcg
- 250–400mcg
- Lower doses sufficient for sleep alone; higher doses support tissue repair
- Injection Timing
- 30–60 min pre-sleep
- 45–60 min pre-sleep
- 30–45 min pre-sleep
- Timing aligned with anticipated slow-wave onset
- Frequency
- Nightly
- 5–6 nights/week
- Athletic models often cycle; aging models require consistency
- Cycle Duration
- 8–12 weeks
- 6–8 weeks on, 2–4 weeks off
- Continuous with periodic assessment
- Sleep protocols tolerate longer duration; recovery protocols benefit from cycling
- Adjunct Compounds
- None or melatonin
- MK 677 (oral ghrelin mimetic)
- None or low-dose Thymalin
- Adjuncts used to address concurrent deficiencies
- Primary Outcome Metric
- Slow-wave sleep duration (polysomnography)
- Recovery biomarkers + subjective sleep quality
- Sleep efficiency + cognitive function
- Metrics tailored to research objective